Ukraine was pharma’s ‘darling’ of clinical trials. As war drags on, will the industry come back?

Before the war, Ukraine was becoming pharma’s “darling” of clinical trials, said Dr. Andreas Muehler, chief medical officer of Immunic Therapeutics, a U.S. and German biotech currently running four multiple sclerosis trials in the country.